(19)
(11) EP 2 305 683 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
04.03.2015 Bulletin 2015/10

(45) Mention of the grant of the patent:
28.01.2015 Bulletin 2015/05

(21) Application number: 10011792.8

(22) Date of filing: 30.03.2005
(51) International Patent Classification (IPC): 
C07D 489/00(2006.01)
A61K 9/00(2006.01)
C07D 489/08(2006.01)
A61K 31/485(2006.01)

(54)

Pharmaceutical dosage form comprising oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone

Pharmazeutische Zubereitung enthaltend Oxycodonhydrochlorid und weniger als 25 ppm 14-Hydroxycodeinon

Composition pharmaceutique contenant de chlorhydrate d'oxycodone et moins que 25 ppm 14-hydroxycodeinone


(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR
Designated Extension States:
AL BA HR LV MK YU

(30) Priority: 30.03.2004 US 557492 P
13.08.2004 US 601534 P
18.10.2004 US 620072 P
31.01.2005 US 648625 P
10.02.2005 US 651778 P

(43) Date of publication of application:
06.04.2011 Bulletin 2011/14

(62) Application number of the earlier application in accordance with Art. 76 EPC:
05730345.5 / 1730151

(73) Proprietor: EURO-CELTIQUE S.A.
1653 Luxembourg (LU)

(72) Inventors:
  • Chapman, Robert
    Downingtown PA 19335 (US)
  • Rider, Lonn S.
    Foster RI 02825 (US)
  • Hong, Qi
    Sharon MA 02607 (US)
  • Kyle, Donald
    Yardley, PA 19067 (US)
  • Kupper, Robert
    East Greenwich RI 02818 (US)

(74) Representative: Maiwald Patentanwalts GmbH 
Elisenhof Elisenstrasse 3
80335 München
80335 München (DE)


(56) References cited: : 
WO-A-2004/016618
US-A- 5 656 295
US-A- 5 266 331
US-A1- 2008 139 814
   
  • KRASSNIG R ET AL: "OPTIMIZATION OF THE SYNTHESIS OF OXYCODONE AND 5-METHYLOXYCODONE", ARCHIV DER PHARMAZIE, VERLAG CHEMIE. WEINHEIM, DE, vol. 329, 1996, pages 325-326, XP008055004,
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).